CONTEXT: Spontaneous coronary artery dissection (SCAD) is a cause of acute coronary syndrome, which predominantly affects healthy women; however, few data define this vulnerable population. OBJECTIVE: To identify demographic and clinical characteristics of patients with SCAD and determine outcomes in a community-based cohort. DESIGN: Retrospective cohort study of patients with SCAD at Kaiser Permanente Northern California during a 10-year period. We compared 111 SCAD cases with 333 healthy, matched controls. MAIN OUTCOME MEASURES: Predisposing factors, treatment modalities, and inhospital and late outcomes. RESULTS: Patients with SCAD had a mean age (standard deviation) of 48.1 (11) years; 92.8% were women, and 49.5% were nonwhite. Of women, 9% were peripartum. Fibromuscular dysplasia was identified in 21.8% of femoral angiograms obtained. With conditional logistic regression, only pregnancy and hyperlipidemia were associated with SCAD compared with controls. Fifty-five patients (49.5%) were successfully treated without revascularization; of the 54 who had urgent percutaneous coronary intervention, 2 required coronary artery bypass grafting for SCAD extension. During a median follow-up of 2.6 years, major adverse cardiovascular events occurred in 8.1% of patients. Pregnancy-related SCAD was not associated with worsened outcomes. However, Emergency Department visits or hospitalizations because of recurrent chest pain occurred frequently for 54% of patients with SCAD. CONCLUSION: The study cohort is comparable to published SCAD cohorts, but notable for a racially and ethnically diverse population. Compared with the controls, only pregnancy and hyperlipidemia were associated with SCAD. For the SCAD cases, major adverse cardiovascular events occurred in 8.1%, and race did not influence outcomes.
CONTEXT: Spontaneous coronary artery dissection (SCAD) is a cause of acute coronary syndrome, which predominantly affects healthy women; however, few data define this vulnerable population. OBJECTIVE: To identify demographic and clinical characteristics of patients with SCAD and determine outcomes in a community-based cohort. DESIGN: Retrospective cohort study of patients with SCAD at Kaiser Permanente Northern California during a 10-year period. We compared 111 SCAD cases with 333 healthy, matched controls. MAIN OUTCOME MEASURES: Predisposing factors, treatment modalities, and inhospital and late outcomes. RESULTS:Patients with SCAD had a mean age (standard deviation) of 48.1 (11) years; 92.8% were women, and 49.5% were nonwhite. Of women, 9% were peripartum. Fibromuscular dysplasia was identified in 21.8% of femoral angiograms obtained. With conditional logistic regression, only pregnancy and hyperlipidemia were associated with SCAD compared with controls. Fifty-five patients (49.5%) were successfully treated without revascularization; of the 54 who had urgent percutaneous coronary intervention, 2 required coronary artery bypass grafting for SCAD extension. During a median follow-up of 2.6 years, major adverse cardiovascular events occurred in 8.1% of patients. Pregnancy-related SCAD was not associated with worsened outcomes. However, Emergency Department visits or hospitalizations because of recurrent chest pain occurred frequently for 54% of patients with SCAD. CONCLUSION: The study cohort is comparable to published SCAD cohorts, but notable for a racially and ethnically diverse population. Compared with the controls, only pregnancy and hyperlipidemia were associated with SCAD. For the SCAD cases, major adverse cardiovascular events occurred in 8.1%, and race did not influence outcomes.
Authors: Marysia S Tweet; Sharonne N Hayes; Sridevi R Pitta; Robert D Simari; Amir Lerman; Ryan J Lennon; Bernard J Gersh; Sherezade Khambatta; Patricia J M Best; Charanjit S Rihal; Rajiv Gulati Journal: Circulation Date: 2012-07-16 Impact factor: 29.690
Authors: Jacqueline Saw; Eve Aymong; Tara Sedlak; Christopher E Buller; Andrew Starovoytov; Donald Ricci; Simon Robinson; Tycho Vuurmans; Min Gao; Karin Humphries; G B John Mancini Journal: Circ Cardiovasc Interv Date: 2014-10-07 Impact factor: 6.546
Authors: Marysia S Tweet; Sharonne N Hayes; Elisabeth Codsi; Rajiv Gulati; Carl H Rose; Patricia J M Best Journal: J Am Coll Cardiol Date: 2017-07-25 Impact factor: 24.094
Authors: Jacqueline Saw; Eve Aymong; G B John Mancini; Tara Sedlak; Andrew Starovoytov; Donald Ricci Journal: Can J Cardiol Date: 2014-01-23 Impact factor: 5.223
Authors: Sebastian Rogowski; Micha T Maeder; Daniel Weilenmann; Philipp K Haager; Peter Ammann; Franziska Rohner; Lucas Joerg; Hans Rickli Journal: Catheter Cardiovasc Interv Date: 2015-12-28 Impact factor: 2.692
Authors: Katherine C Michelis; Jeffrey W Olin; Daniella Kadian-Dodov; Valentina d'Escamard; Jason C Kovacic Journal: J Am Coll Cardiol Date: 2014-09-09 Impact factor: 24.094
Authors: Sharonne N Hayes; Esther S H Kim; Jacqueline Saw; David Adlam; Cynthia Arslanian-Engoren; Katherine E Economy; Santhi K Ganesh; Rajiv Gulati; Mark E Lindsay; Jennifer H Mieres; Sahar Naderi; Svati Shah; David E Thaler; Marysia S Tweet; Malissa J Wood Journal: Circulation Date: 2018-02-22 Impact factor: 29.690
Authors: Vanessa L Kronzer; Alex D Tarabochia; Angie S Lobo Romero; Nicholas Y Tan; Thomas J O'Byrne; Cynthia S Crowson; Tamiel N Turley; Elena Myasoedova; John M Davis; Claire E Raphael; Rajiv Gulati; Sharonne N Hayes; Marysia S Tweet Journal: J Am Coll Cardiol Date: 2020-11-10 Impact factor: 24.094